Trial intelligence / Profile preview

RIOT Trial: Reduced Immunosuppression in Older Renal Transplant Recipients

NCT06568549Phase 4Recruiting

Sponsor
Mayo Clinic
Start
Jun 2025
Primary completion
Dec 2030
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of mycophenolate mofetil in kidney transplant rejection, sponsored by Mayo Clinic. Started Jun 2025; status: recruiting.

02

Drugs

mycophenolate mofetil
03

Conditions

kidney transplant rejection

Beyond the preview

Go deeper on NCT06568549.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06568549.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call